Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Axe Compute Inc.Predictive Oncology Reports Revenue Surge to $110K, Reduces Net Loss in Latest 10-Q Filing
INTELLIGENT PROTECTION MANAGEMENT CORP.Intelligent Protection Management Corp. Reports 1931.9% Revenue Increase and Net Income Turnaround
Transcode Therapeutics, Inc.TransCode Therapeutics Reports Increased Losses and Financial Challenges in Q1 2025
Microbot Medical Inc.Microbot Medical Inc. Reports Q1 2025 Financial Results with $2.6 Million Net Loss
TMC the metals Co Inc.TMC the Metals Company Reports $20.6 Million Net Loss in Q1 2025, Seeks Regulatory Approvals
EGAIN CorpeGain Corporation Reports Decline in Revenue and Profitability for Q3 Fiscal Year 2025
EVOLUTION PETROLEUM CORPEvolution Petroleum Reports Q3 Fiscal 2025 Net Loss of $2.2 Million
CalciMedica, Inc.CalciMedica Reports $5 Million Net Loss in Q1 2025 Amid Increased R&D Expenses
Enliven Therapeutics, Inc.Enliven Therapeutics Reports $28.5 Million Net Loss in Q1 2025 Amid Increased R&D Costs
IMPACT BIOMEDICAL INC.Impact BioMedical Reports $1.278 Million Net Loss in Q1 2025, Increases Costs and Acquires Assets
GEE Group Inc.GEE Group Reports $33.1 Million Net Loss and Revenue Decline in Fiscal Second Quarter
Cytosorbents CorpCytoSorbents Reports Q1 2025 Financial Results with $8.7M Revenue
MARCHEX INCMarchex Reports $11.4 Million Revenue in Q1 2025, Net Loss Increases to $1.98 Million
PROVECTUS BIOPHARMACEUTICALS, INC.Provectus Biopharmaceuticals Reports Q1 2025 Financial Results with Increased Losses and Rising Grant Revenue
EMPIRE PETROLEUM CORPEmpire Petroleum Corporation Reports Q1 2025 Financial Results with Revenue Decline
Spire Global, Inc.Spire Global Reports 31% Revenue Decline in Q1 2025, Despite Increase in Annual Recurring Revenue
Zentalis Pharmaceuticals, Inc.Zentalis Pharmaceuticals Reports $48.3 Million Net Loss Amid Financial Challenges
TENAX THERAPEUTICS, INC.Tenax Therapeutics Reports $10.4 Million Net Loss and $111.4 Million Cash Reserves for Q1 2025
SYPRIS SOLUTIONS INCSypris Solutions Reports $29.5 Million Revenue in Q1 2025, 17% Decline Year-Over-Year
GRAIL, Inc.GRAIL Reports $31.8 Million Revenue in Q1 2025, Driven by 24% Increase in Screening Revenue
Bionano Genomics, Inc.Bionano Genomics Reports 26% Revenue Decline to $6.46 Million in Q1 2025
OptiNose, Inc.OptiNose Reports 24% Revenue Growth to $18.5 Million in Q1 2025 Amid Increased Losses
Presurance Holdings, Inc.Conifer Holdings Reports Decrease in Net Income and Revenue in Q1 2025
Adverum Biotechnologies, Inc.Adverum Biotechnologies Reports $47M Net Loss and Financial Challenges in Latest 10-Q
FACT II Acquisition Corp.FACT II Acquisition Corp. Reports $1.45 Million Net Income in Q1 2025